Goncu, Emek KocatürkAktan, ŞebnemAtakan, NilgünBaşkan, Emel BülbülErdem, TeomanKoca, RafetSavk, EkinTaşkapan, OktayUtas, Serap2024-11-192024-11-192016-01-011019-214Xhttps://doi.org/10.4274/turkderm.22438https://jag.journalagent.com/turkderm/pdfs/TURKDERM_50_3_82_98.pdfhttps://hdl.handle.net/11452/48131Background and Design: Albeit an easily recognized disease, urticaria features many diverse approaches which rationalize the need for an algorithm for the diagnosis, classification, etiopathogenesis, diagnostic evaluation and therapeutic approach. Therefore, authors from Dermatoallergy Working Group of the Turkish Society of Dermatology and the Turkish Dermatoimmunology and Allergy Association aimed to create an urticaria guideline for the diagnosis, treatment and follow-up of urticaria.Materials and Methods: Each section of the guideline has been written by a different author. The prepared sections were evaluated in part by e-mail correspondence and have taken its final form after revision in the last meeting held by the participation of all authors.Results: The guideline includes the description, classification, pathophysiology as well as diagnosis and treatment of urticaria. Urticaria is classified into two main types: acute urticaria and chronic urticaria while chronic urticaria is further subdivided into spontaneous urticaria and inducible urticaria. The first step of treatment includes standard doses of H1-blockers. In patients who do not respond to the first step, antihistamine dose is increased up to four times; if unsuccessful, another second-generation antihistamine is given in the same dose. In antihistamine-resistant cases, introduction of omalizumab is required. Omalizumab dose may be increased in patients failing to respond to the standard dose. In patients unresponsive to omalizumab, cyclosporine-A may be given. Routine diagnostic tests are not recommended in acute urticaria. In chronic urticaria, erythrocyte sedimentation rate, differential blood count and C-reactive protein testing are the only investigations that are needed routinely.Conclusion: Chronic urticaria is a disease that can be challenging for the physician in terms of treatment and follow-up. Depending on evidence-based data (and individual experiences), this guideline will have a leading role in the diagnosis and treatment of urticaria and help the physician to overcome the challenges in the management.eninfo:eu-repo/semantics/openAccessChronic idiopathic urticariaQuality-of-lifePseudoallergen-free dietFc-epsilon-riDouble-blindNatural-historyCyclosporine-aMycophenolate-mofetilHelicobacter-pyloriDisease severityAcute urticariaAlgorithmAngioedemaChronic idiopathic urticariaChronic spontaneous urticariaGuidelinePhysical urticariaTreatment urticariaTurkeyScience & technologyLife sciences & biomedicineDermatologyArticle000388299400002829850310.4274/turkderm.224381308-6294